Financing deals

CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

Derived from Current Agreements, our editors have selected notable financing deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.

For comprehensive access to all life science deals as they are announced:

Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now

Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now

Featured financing deals

All financing deals: Deal Monitor | Current Agreements

Veracyte banks $40 million private placement

April 28, 2015 : financing

Veracyte has entered into a definitive agreement to sell approximately $40 million of its common stock in a private placement more »

Dimension Therapeutics snags series B for $65mn

April 22, 2015 : financing, financings

Dimension Therapeutics announced the successful completion of a Series B financing totaling $65 million more »

Innocrin raises $28 million in series D financing

April 15, 2015 : financing

Innocrin Pharmaceuticals announced the completion of a $28 million Series D financing round more »

Mesoblast banks $45mn financing from Celgene

April 14, 2015 : big biotech, Celgene, financing

Mesoblast has entered into an Agreement with Celgene more »

Edge Therapeutics bags $56mn series C2

April 13, 2015 : financings

Edge Therapeutics has raised approximately $72.5 million in gross proceeds from two recently completed private financing rounds more »

Natera raises $55mn private placement

April 9, 2015 : financing

Natera has raised approximately $55.5 million in funding led by Silicon Valley life sciences investment firm Sofinnova Ventures more »

Nabriva banks $120mn series B

April 9, 2015 : financing

Nabriva Therapeutics announced the successful completion of a $120 million Series B financing more »

True North Therapeutics banks $32mn series B

April 9, 2015 : financing

True North Therapeutics has completed a $35 million Series B equity financing more »

Thrasos bags $21 million financing led by SR One

April 1, 2015 :

Thrasos Therapeutics has completed a $21M Series D financing led by BDC Capital and SR One more »

Immunogen gains $200 million from Kadcyla royalty financing

March 31, 2015 : financing

ImmunoGen announced a $200 million non-dilutive royalty transaction with funds managed by TPG Special Situations Partners more »

« Page 1, 2, 3, 4 ... 106, »

Derived from Current Agreements, more featured partnering deals by category:

Big pharma

AstraZeneca and Innate Pharma in IPH2201 deal

April 28, 2015

Celgene and AstraZeneca in MEDI4736 pact

April 28, 2015

Teva bids to acquire Mylan as Perrigo rejects approach

April 22, 2015

View more featured deals | all deals at Deal Monitor

Big biotech

Athersys and Chugai announce pharma licensing deal for ischemic stroke

March 3, 2015

Teva enters into pharma licensing deal with Eagle Pharmaceuticals for cancer drug

February 18, 2015

Genzyme and Voyager in $845 million AAV gene therapy pact

February 12, 2015

View more featured deals | all deals at Deal Monitor

Pharma

Lilly snags rights to Erbitux from BMS

April 20, 2015

Ventana and Astellas in automated tissue diagnostics pact

April 15, 2015

Janssen and Ichor Medical enter hep B vaccine delivery alliance

April 14, 2015

View more featured deals | all deals at Deal Monitor

Biotech

Curis and Aurigene in immuno-oncology pact

January 22, 2015

Agile Therapeutics bags $20 million in private placement

January 21, 2015

Celgene licenses AG-120 from Agios

January 14, 2015

View more featured deals | all deals at Deal Monitor

Diagnostics

LabCorp has acquired Covance for $6.1 billion

November 4, 2014

Qiagen and Astellas form a biotech partnership to develop companion diagnostics

October 30, 2014

In m&a news: Optum has bought Alere Health for $600 million

October 30, 2014

View more featured deals | all deals at Deal Monitor

Medical device

BTG acquires emphysema innovator PneumRx

December 5, 2014

Conventus Orthopaedics banks series AA financing for $24 million

December 4, 2014

Xeltis secures series B financing for $34 million

December 3, 2014

View more featured deals | all deals at Deal Monitor

Drug delivery

M&A news: Acorda has purchased Civitas Therapeutics

September 25, 2014

NeuroDerm files for $250 million in IPO financing

September 17, 2014

Foamix Pharma files for $75 million in IPO financing

August 15, 2014

View more featured deals | all deals at Deal Monitor

Print Friendly, PDF & Email
cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new2gif
e79banner300x150gif
e78banner300x150animgif